|
Invitae Corp Note 2.000% 9/0 (Principal)
|
5.2 |
$246M |
|
163M |
1.50 |
|
Viatris
(VTRS)
|
5.1 |
$241M |
|
17M |
13.97 |
|
Nevro Corp Note 1.750% 6/0 (Principal)
|
3.5 |
$168M |
|
116M |
1.45 |
|
Aerie Pharmaceuticals Note 1.500%10/0 (Principal)
|
3.2 |
$154M |
|
150M |
1.03 |
|
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
2.8 |
$132M |
|
80M |
1.65 |
|
Edgewise Therapeutics
(EWTX)
|
2.7 |
$128M |
|
3.9M |
32.50 |
|
Centene Corporation
(CNC)
|
2.7 |
$127M |
|
2.0M |
63.91 |
|
Boston Scientific Corporation
(BSX)
|
2.3 |
$110M |
|
2.9M |
38.65 |
|
Dfp Healthcare Acquisitns Com Cl A
|
2.2 |
$104M |
|
11M |
9.96 |
|
Alexion Pharmaceuticals
|
1.9 |
$89M |
|
579k |
152.91 |
|
Biogen Idec
(BIIB)
|
1.8 |
$87M |
|
310k |
279.75 |
|
Adapthealth Corp Com Cl A
(AHCO)
|
1.8 |
$84M |
|
2.3M |
36.76 |
|
Deerfield Healthcare Tech Ac Com Cl A
|
1.7 |
$82M |
|
6.8M |
12.12 |
|
Pacira Pharmaceuticals
(PCRX)
|
1.7 |
$82M |
|
1.2M |
70.09 |
|
Insulet Corp Note 0.375% 9/0 (Principal)
|
1.6 |
$76M |
|
58M |
1.32 |
|
Larimar Therapeutics
(LRMR)
|
1.6 |
$75M |
|
5.1M |
14.61 |
|
Neurocrine Biosciences
(NBIX)
|
1.5 |
$71M |
|
725k |
97.25 |
|
Mirum Pharmaceuticals
(MIRM)
|
1.4 |
$68M |
|
3.4M |
19.82 |
|
Insmed Note 1.750% 1/1 (Principal)
|
1.4 |
$68M |
|
61M |
1.11 |
|
Revolution Medicines
(RVMD)
|
1.4 |
$66M |
|
1.4M |
45.88 |
|
Cytokinetics Com New
(CYTK)
|
1.3 |
$60M |
|
2.6M |
23.26 |
|
Owens & Minor
(OMI)
|
1.2 |
$58M |
|
1.5M |
37.59 |
|
Acutus Medical
(AFIB)
|
1.2 |
$58M |
|
4.3M |
13.37 |
|
Zimmer Holdings
(ZBH)
|
1.2 |
$57M |
|
357k |
160.08 |
|
Organogenesis Hldgs
(ORGO)
|
1.1 |
$55M |
|
3.0M |
18.22 |
|
Molina Healthcare
(MOH)
|
1.1 |
$54M |
|
232k |
233.76 |
|
Terns Pharmaceuticals
(TERN)
|
1.1 |
$52M |
|
2.3M |
22.00 |
|
Alphatec Hldgs Com New
(ATEC)
|
1.1 |
$51M |
|
3.2M |
15.79 |
|
Orchard Therapeutics Ads
|
1.1 |
$51M |
|
6.9M |
7.26 |
|
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
1.0 |
$48M |
|
58M |
0.82 |
|
Clovis Oncology Note 2.500% 9/1 (Principal)
|
1.0 |
$46M |
|
49M |
0.94 |
|
Ortho Clinical Diagnostics H Ord Shs
|
1.0 |
$45M |
|
2.4M |
19.30 |
|
Brookdale Senior Living
(BKD)
|
1.0 |
$45M |
|
7.5M |
6.05 |
|
Tabula Rasa Healthcare Note 1.750% 2/1 (Principal)
|
0.9 |
$45M |
|
45M |
0.99 |
|
Oncorus
|
0.9 |
$44M |
|
3.1M |
13.92 |
|
Pulmonx Corp
(LUNG)
|
0.9 |
$43M |
|
937k |
45.74 |
|
Rhythm Pharmaceuticals
(RYTM)
|
0.9 |
$42M |
|
2.0M |
21.27 |
|
Reata Pharmaceuticals Cl A
|
0.9 |
$42M |
|
420k |
99.70 |
|
Springworks Therapeutics
(SWTX)
|
0.9 |
$41M |
|
559k |
73.57 |
|
Novavax Note 3.750% 2/0 (Principal)
|
0.9 |
$41M |
|
25M |
1.64 |
|
Nuvasive Note 0.375% 3/1 (Principal)
|
0.9 |
$41M |
|
40M |
1.02 |
|
Constellation Pharmceticls I
|
0.8 |
$40M |
|
1.7M |
23.39 |
|
Inozyme Pharma
(INZY)
|
0.8 |
$39M |
|
2.0M |
19.80 |
|
BioDelivery Sciences International
|
0.8 |
$37M |
|
9.5M |
3.91 |
|
Puma Biotechnology
(PBYI)
|
0.8 |
$37M |
|
3.8M |
9.72 |
|
Iveric Bio
|
0.7 |
$36M |
|
5.8M |
6.18 |
|
Apria
|
0.7 |
$34M |
|
1.2M |
27.93 |
|
Protagonist Therapeutics
(PTGX)
|
0.7 |
$33M |
|
1.3M |
25.90 |
|
Nuvation Bio Com Cl A
(NUVB)
|
0.7 |
$31M |
|
3.0M |
10.45 |
|
Hill-Rom Holdings
|
0.6 |
$31M |
|
280k |
110.48 |
|
Apellis Pharmaceuticals Note 3.500% 9/1 (Principal)
|
0.6 |
$31M |
|
22M |
1.40 |
|
Xeris Pharmaceuticals Note 5.000% 7/1 (Principal)
|
0.6 |
$30M |
|
18M |
1.69 |
|
Acceleron Pharma
|
0.6 |
$30M |
|
220k |
135.61 |
|
Xeris Pharmaceuticals
|
0.6 |
$30M |
|
6.6M |
4.51 |
|
Graybug Vision Com Shs
|
0.6 |
$29M |
|
5.3M |
5.55 |
|
Pharvaris N V
(PHVS)
|
0.6 |
$29M |
|
1.0M |
27.98 |
|
Itamar Med Sponsored Ads
|
0.6 |
$29M |
|
1.2M |
23.95 |
|
Instil Bio
|
0.6 |
$28M |
|
1.1M |
25.08 |
|
Sotera Health
(SHC)
|
0.6 |
$28M |
|
1.1M |
24.96 |
|
Amicus Therapeutics
(FOLD)
|
0.6 |
$27M |
|
2.7M |
9.88 |
|
BioCryst Pharmaceuticals
(BCRX)
|
0.6 |
$27M |
|
2.6M |
10.17 |
|
Kalvista Pharmaceuticals
(KALV)
|
0.6 |
$26M |
|
1.0M |
25.69 |
|
Profound Med Corp Com New
(PROF)
|
0.5 |
$26M |
|
1.3M |
20.14 |
|
Generation Bio
|
0.5 |
$26M |
|
898k |
28.46 |
|
Black Diamond Therapeutics
(BDTX)
|
0.5 |
$25M |
|
1.0M |
24.26 |
|
Fate Therapeutics
(FATE)
|
0.5 |
$25M |
|
304k |
82.45 |
|
Silk Road Medical Inc Common
|
0.5 |
$25M |
|
489k |
50.65 |
|
Adverum Biotechnologies
|
0.5 |
$24M |
|
2.4M |
9.86 |
|
Deciphera Pharmaceuticals
|
0.5 |
$24M |
|
529k |
44.84 |
|
Meridian Bioscience
|
0.5 |
$23M |
|
889k |
26.25 |
|
Alector
(ALEC)
|
0.4 |
$21M |
|
1.1M |
20.14 |
|
Montes Archimedes Acquisitio Unit 09/30/2025 (Principal)
|
0.4 |
$20M |
|
2.0M |
10.20 |
|
Blueprint Medicines
(BPMC)
|
0.4 |
$20M |
|
209k |
97.23 |
|
Wave Life Sciences SHS
(WVE)
|
0.4 |
$20M |
|
3.5M |
5.61 |
|
Nevro Corp Note 2.750% 4/0 (Principal)
|
0.4 |
$18M |
|
12M |
1.52 |
|
Chimerix
(CMRX)
|
0.4 |
$18M |
|
1.8M |
9.64 |
|
American Well Corp Cl A
|
0.4 |
$17M |
|
991k |
17.37 |
|
Ardelyx
(ARDX)
|
0.4 |
$17M |
|
2.6M |
6.62 |
|
Ptc Therapeutics Note 3.000% 8/1 (Principal)
|
0.4 |
$17M |
|
15M |
1.15 |
|
Certara Ord
(CERT)
|
0.3 |
$16M |
|
600k |
27.30 |
|
Annexon
(ANNX)
|
0.3 |
$16M |
|
584k |
27.84 |
|
Medavail Holdings Ord
|
0.3 |
$16M |
|
1.1M |
14.00 |
|
Pacific Biosciences of California
(PACB)
|
0.3 |
$16M |
|
468k |
33.31 |
|
Bioventus Com Cl A
(BVS)
|
0.3 |
$15M |
|
957k |
15.28 |
|
Rubius Therapeutics
|
0.3 |
$15M |
|
550k |
26.50 |
|
Bluebird Bio
|
0.3 |
$15M |
|
480k |
30.15 |
|
Stryker Corporation
(SYK)
|
0.3 |
$14M |
|
59k |
243.58 |
|
Pmv Pharmaceuticals
(PMVP)
|
0.3 |
$14M |
|
424k |
32.89 |
|
Achilles Therapeutics Sponsored Ads
(ACHL)
|
0.3 |
$13M |
|
800k |
16.55 |
|
Highcape Cap Acquisition Cor Unit 09/30/2027
|
0.3 |
$13M |
|
1.0M |
12.92 |
|
Autolus Therapeutics Spon Ads
(AUTL)
|
0.3 |
$12M |
|
2.1M |
5.73 |
|
Signify Health Cl A Com
|
0.2 |
$12M |
|
400k |
29.26 |
|
Bolt Biotherapeutics
|
0.2 |
$12M |
|
350k |
32.91 |
|
Neuronetics
(STIM)
|
0.2 |
$11M |
|
919k |
12.37 |
|
Pet Acquisition LLC -Class A
(WOOF)
|
0.2 |
$11M |
|
500k |
22.16 |
|
Sarissa Capital Acquisitn Unit 10/23/2027
|
0.2 |
$11M |
|
1.0M |
10.83 |
|
Kinnate Biopharma
|
0.2 |
$11M |
|
345k |
31.16 |
|
Dyne Therapeutics
(DYN)
|
0.2 |
$11M |
|
686k |
15.53 |
|
Bioatla
(BCAB)
|
0.2 |
$10M |
|
205k |
50.84 |
|
Revolution Healthcar Aq Corp Unit 03/18/20266
|
0.2 |
$10M |
|
1.0M |
10.05 |
|
Medtech Acquisition Corp Unit 12/18/2025
|
0.2 |
$10M |
|
1.0M |
10.05 |
|
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.2 |
$10M |
|
1.0M |
10.01 |
|
Senior Connect Acquisitn Cor Unit 12/09/2023
|
0.2 |
$10M |
|
1.0M |
10.01 |
|
Avidity Biosciences Ord
(RNA)
|
0.2 |
$9.9M |
|
454k |
21.81 |
|
Olema Pharmaceuticals
(OLMA)
|
0.2 |
$9.0M |
|
271k |
33.18 |
|
Aerie Pharmaceuticals
|
0.2 |
$8.8M |
|
494k |
17.87 |
|
Cogent Biosciences
(COGT)
|
0.2 |
$8.8M |
|
1.0M |
8.78 |
|
Turning Point Therapeutics I
|
0.2 |
$7.9M |
|
84k |
94.59 |
|
Innovage Hldg Corp
(INNV)
|
0.2 |
$7.7M |
|
300k |
25.79 |
|
Cm Life Sciences Ii Unit 02/25/2028
|
0.2 |
$7.7M |
|
600k |
12.80 |
|
Turmeric Acquisition Corp Unit 10/08/2025
|
0.2 |
$7.5M |
|
750k |
10.00 |
|
Immunocore Hldgs Ads
(IMCR)
|
0.2 |
$7.3M |
|
172k |
42.57 |
|
Ignyte Acquisition Corp Unit 01/05/2026
|
0.2 |
$7.3M |
|
725k |
10.02 |
|
4d Molecular Therapeutics In
(FDMT)
|
0.1 |
$6.5M |
|
150k |
43.38 |
|
Delcath Sys Com New
(DCTH)
|
0.1 |
$6.2M |
|
500k |
12.42 |
|
Gracell Biotechnologies Sponsored Ads
|
0.1 |
$6.2M |
|
400k |
15.40 |
|
Benefitfocus Note 1.250%12/1 (Principal)
|
0.1 |
$5.9M |
|
6.5M |
0.91 |
|
Sensei Biotherapeutics
|
0.1 |
$5.4M |
|
375k |
14.53 |
|
Intersect Ent
|
0.1 |
$5.3M |
|
256k |
20.88 |
|
Cabaletta Bio
(CABA)
|
0.1 |
$5.2M |
|
464k |
11.10 |
|
Orion Acquisition Corp Unit 02/19/2026
|
0.1 |
$5.0M |
|
500k |
10.00 |
|
Consonance Hfw Acquisition C Unit 99/99/9999
|
0.1 |
$4.9M |
|
500k |
9.76 |
|
Butterfly Network *w Exp 05/27/202
(BFLY.WS)
|
0.1 |
$4.7M |
|
733k |
6.45 |
|
Lumos Pharma
|
0.1 |
$4.4M |
|
373k |
11.70 |
|
Landos Biopharma
|
0.1 |
$4.3M |
|
450k |
9.63 |
|
Neogenomics Note 0.250% 1/1 (Principal)
|
0.1 |
$2.5M |
|
2.5M |
1.01 |
|
Metacrine Ord
|
0.0 |
$1.7M |
|
278k |
6.20 |
|
Dfp Healthcare Acquisitns *w Exp 03/31/202
|
0.0 |
$1.7M |
|
1.3M |
1.35 |
|
Deerfield Healthcare Tech Ac *w Exp 07/16/202
|
0.0 |
$1.6M |
|
672k |
2.31 |
|
Cerevel Therapeutics Hldng I *w Exp 06/09/202
(CEREW)
|
0.0 |
$718k |
|
167k |
4.31 |
|
Imara
|
0.0 |
$671k |
|
80k |
8.44 |
|
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.0 |
$445k |
|
167k |
2.67 |
|
Windtree Therapeutics
|
0.0 |
$49k |
|
20k |
2.43 |